can glp 1 be used in type 1 diabetes GLP-1 receptor agonists are increasingly to treat 2 and obesity, and trials have shown reductions cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 receptor agonists and beyond.
Description
I think these companies that have been producing competitive drugs have really been skirting, threading the needle on laws with things like micro dosing, etc
Endocrinology (2019) 160(5):116674
But unfortunately, BMI is still used in clinical settings, especially to prescribe GLP-1s
The percentage of participants who discontinued the medication due to AE ranged between 20 and 29%
Ozempic and Mounjaro: Here's where it gets really nuanced
